News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
88
Sources here
16
Companies here
6
Search results Stored financial headlines

Active search

88 matching headlines

Ticker or company: LOVEMain company stories
Clear

Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Clover Health Investments has delivered a very strong 227.7% return over the past 3 years, yet the share price around US$4.49 now lines up …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10.58 million to net income of US$28 million. Alongside this shift to profitability, the company …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Clover Health's Q2 Earnings Call Clover Health's second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter's performance to the expansion of its …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Lovesac Company (NASDAQ:LOVE) Receives Average Recommendation of "Moderate Buy" from Analysts

The Lovesac Company (NASDAQ:LOVE) has received an average recommendation of "Moderate Buy" from analysts, with four out of five rating it a buy and one a sell. The average 12-month price target is $22.67, exceeding the current share price of $17.65. Despite a slight …

LOVE main company
Sharemaestro market context Trend signal active 52 weeks -9.5% LOVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting

Clover Health's Interim CFO, Joseph Clay Thornton, was granted 54,347 Restricted Stock Units (RSUs) of Class A Common Stock. These RSUs, valued at $0, will vest over a four-year period, with 25% vesting on August 12, 2027, and the remainder in quarterly installments, fully …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth

Key Points Interested in Clover Health Investments, Corp.? Here are five stocks we like better. Clover Health is targeting its first full year of GAAP profitability in 2026, alongside approximately 50% membership growth, after reporting sustained adjusted EBITDA profitability and improved operating leverage. The …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Clover Health CEO Andrew Toy sells $408,260 in stock By Investing.com

Clover Health CEO Andrew Toy sold 87,798 shares of the company's Class A Common Stock for approximately $408,260. This "sell to cover" transaction was not discretionary but mandated to fulfill tax withholding obligations tied to previously granted restricted stock units. Following this, Mr. Toy …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CLOV (Nasdaq: CLOV) discloses planned 85,704-share sale by Andrew Toy

Clover Health Investments, Corp. (Nasdaq: CLOV) has disclosed a planned sale of 85,704 shares of Class A common stock by Andrew Toy through Morgan Stanley Smith Barney LLC, valued at approximately $391,667.28. These shares originate from Restricted Stock Units acquired as compensation on August …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Clover Health (CLOV) CEO Andrew Toy sells 87,798 shares for tax withholding

Clover Health CEO Andrew Toy sold 87,798 shares of Class A Common Stock for $408K on August 10, 2026, at a weighted average price of $4.65 per share. This sale was non-discretionary and conducted solely to cover tax withholding obligations associated with the final …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Lowers Stake in The Lovesac Company $LOVE

Dimensional Fund Advisors LP reduced its holdings in The Lovesac Company (NASDAQ:LOVE) by 13.1% in the first quarter, selling 88,758 shares but still retaining 587,699 shares valued at $8.68 million. Despite this, institutional investors and hedge funds own a significant 91.32% of the company's …

LOVE main company
Sharemaestro market context Trend signal active 52 weeks -9.5% LOVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lovesac Co (LOVE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lovesac Co (LOVE) has an earnings forecast score of 8.33, ranking 3rd in the Household Goods industry, with an average price target of $29.00 from analysts. The stock is currently rated as a "Buy" by 6 analysts, who predict a 35.62% upside. Expected revenue …

LOVE main company
Sharemaestro market context Trend signal active 52 weeks -9.5% LOVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kanen Wealth Management LLC Takes $8.06 Million Position in The Lovesac Company $LOVE

Kanen Wealth Management LLC has acquired a new stake of 545,963 shares in The Lovesac Company (NASDAQ:LOVE) worth approximately $8.06 million, making it their 10th largest holding. Institutional ownership in Lovesac is high at 91.32%, with other firms also increasing their positions. Analysts maintain …

LOVE main company
Sharemaestro market context Trend signal active 52 weeks -9.5% LOVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Anson Funds Management LP Has $17.49 Million Holdings in The Lovesac Company $LOVE

Anson Funds Management LP reduced its stake in The Lovesac Company (NASDAQ:LOVE) by 13.6% in the first quarter, selling 186,679 shares but still holding 1.18 million shares valued at $17.49 million, representing an 8.01% stake. Despite this, Lovesac's recent quarterly revenue of $138.2 million …

LOVE main company
Sharemaestro market context Trend signal active 52 weeks -9.5% LOVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lovesac Co (LOVE) Financial Health: Profitability & Balance Sheet Analysis

Lovesac Co (LOVE) holds a financial score of 7.35, placing it 10th out of 23 companies in the Household Goods industry, indicating stable financial health and average operating efficiency. The company's latest quarterly revenue was $138.20 million, a 0.13% year-over-year decrease, with net profit …

LOVE main company
Sharemaestro market context Trend signal active 52 weeks -9.5% LOVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context